These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1605654

  • 1. [Recent progress of endocrine therapy in breast cancer].
    Nomura Y.
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):783-9. PubMed ID: 1605654
    [Abstract] [Full Text] [Related]

  • 2. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A.
    J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148
    [Abstract] [Full Text] [Related]

  • 3. [Developments in endocrine therapy for breast cancer].
    Matsui A, Ikeda T, Jinno H, Tajima G, Hohjou T, Tokura H, Mitsui Y, Asaga S, Muto T, Kitajima M.
    Gan To Kagaku Ryoho; 2002 Jul 10; 29(7):1138-45. PubMed ID: 12145993
    [Abstract] [Full Text] [Related]

  • 4. [Adjuvant endocrine therapy for breast cancer].
    Iino Y, Takei H, Morishita Y.
    Gan To Kagaku Ryoho; 1995 Apr 10; 22 Suppl 1():81-7. PubMed ID: 7747997
    [Abstract] [Full Text] [Related]

  • 5. Update on endocrine therapy for breast cancer.
    Buzdar AU, Hortobagyi G.
    Clin Cancer Res; 1998 Mar 10; 4(3):527-34. PubMed ID: 9533518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of ovarian ablation in the management of breast cancer.
    Wirk B.
    Breast J; 2005 Mar 10; 11(6):416-24. PubMed ID: 16297086
    [Abstract] [Full Text] [Related]

  • 14. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
    Spicer J, Ellis P.
    Cancer Lett; 2007 Apr 18; 248(2):165-74. PubMed ID: 16919870
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endocrine therapy for early breast cancer.
    Hussain SA, Williams S, Stevens A, Rea DW.
    Expert Rev Anticancer Ther; 2004 Oct 18; 4(5):877-88. PubMed ID: 15485321
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Aromatase inhibitors in the adjuvant therapy of breast cancer].
    Bauerschlag D, Schem C, Maass N, Jonat W.
    Gynakol Geburtshilfliche Rundsch; 2005 Jun 18; 45(3):132-6. PubMed ID: 15990437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.